Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Clinton Health Access Initiative (CHAI) is a global health organization dedicated to saving lives and reducing the burden of disease in low-and middle-income countries. Founded in 2002 as the Clinton HIV/AIDS Initiative, it initially focused on addressing the HIV/AIDS crisis by negotiating price reductions for antiretroviral drugs and diagnostics. CHAI works by partnering with governments to strengthen health systems and with the private sector to improve market dynamics for life-saving medicines. The organization has played a pivotal role in scaling up HIV treatment globally, helping to lower the cost of treatment by over 90 percent. Today, CHAI's work extends beyond HIV to include malaria, tuberculosis, hepatitis, and maternal and child health. It operates as a non-profit entity, focusing on sustainable health solutions and market-based interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinton HIV.